Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Anthropic is calling for joint efforts to slow the development of AI, using arms control agreements as a model. But that's a ...

Anthropic is changing course after facing criticism for quietly downgrading certain requests to its most capable AI model. On ...

As AI companies explore systems that can help develop more advanced AI, policymakers are beginning to debate whether new ...

Casar said the U.S. government can't sit by idly and do nothing. It needs to do something to address the enormous impact of ...

Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he ...

Anthropic got the ball rolling on thinking about a pause on AI-builds-AI. I clarify the ins and outs. An AI Insider analysis and scoop.

Venture capitalist Chamath Palihapitiya said artificial intelligence (AI) could reshape the U.S. economy by significantly ...

A Generalized Recursive Regular Expression Synthesis Framework" by Professor Sangki Ko's research team from the Depa ...

Industry chiefs say a looming breakthrough might deliver superintelligence. Safety experts say we’re not ready for it. Read ...